Company: BSX
Filing Date: 2025-02-18
Form Type: 10-K
Source: 0000885725-25-000011
Chunk: 126

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-18
Form: 10-K
Item: Item 8
Chunk 126
---
 — Ending$17 $17 $17 Treasury StockBeginning$(2,251)$(2,251)$(2,251)Repurchase of common stock— — — Ending$(2,251)$(2,251)$(2,251)Additional paid-in capitalBeginning$20,647 $20,289 $19,986 Conversion of mandatory convertible preferred stock to common stock— (0)— Impact of stock-based compensation plans409 359 303 Ending$21,056 $20,647 $20,289 Retained earnings (Accumulated deficit)Beginning$819 $(750)$(1,392)Net income (loss)1,846 1,592 698 Net (income) loss attributable to noncontrolling interests8 1 — Preferred stock dividends— (23)(55)Ending$2,673 $819 $(750)Accumulated other comprehensive income (loss), net of tax Beginning$49 $269 $263 Changes in other comprehensive income (loss), net of tax:Foreign currency translation adjustment232 (95)(94)Derivative financial instruments1 (115)63 Defined benefit pensions and other items(8)(9)37 Ending$275 $49 $269 Total stockholders' equity$21,770 $19,282 $17,573 Noncontrolling interestsBeginning$248 $— $— Net income (loss) attributable to noncontrolling interests(8)(1)— Changes in other comprehensive income (loss)(7)(10)— Changes to noncontrolling ownership interest— 259 — Ending$233 $248 $— Total equity$22,003 $19,530 $17,573 

See notes to the consolidated financial statements. Amounts may not foot due to rounding.

69

BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWSYear Ended December 31,(in millions)202420232022Net income (loss) $1,846 $1,592 $698 Adjustments to reconcile net income (loss) to cash provided by (used for) operating activitiesLoss (gain) on disposal of businesses and assets— — 22 Depreciation and amortization1,269 1,196 1,136 Deferred and prepaid